Stocks News

LAST PRICE
78.3600
TODAY'S CHANGE (%)
Trending Down-1.0700 (-1.3471%)

Bid / Lots
75.0000/ 2
Ask / Lots
81.5000/ 1
Open / Previous Close
79.5900 / 79.4300
Day Range
Low 77.9800
High 82.2000
52 Week Range
Low 1.4500
High 89.1099
Volume
185,920
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Sleep Number, Getty Images, and More Stocks See Action From Activist Investors -- Barrons.com, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: SNBR, HR, GETY, PSFE, WGS
  
  These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 21 through Nov. 27, 2024. Source: VerityData
Nov 22, 2024
- GeneDx to Participate in Upcoming Investor Conference, from 4:05PM ET on Friday Nov 22, 2024 by Dow Jones
  4:05PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: WGS
  
  GeneDx to Participate in Upcoming Investor Conference
  STAMFORD, Conn.--(BUSINESS WIRE)--November 22, 2024--
  GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference from December 3-5 in New York City, NY. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 1:00 p.m. ET.
- GeneDx Holdings Insider Sold Shares Worth $3,316,880, According to a Recent SEC Filing, from 3:09AM ET on Friday Nov 22, 2024 by MT Newswires
  3:09AM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: WGS
  03:09 AM EST, 11/22/2024 (MT Newswires) -- Jason Ryan, Director, on November 19, 2024, sold 47,000 shares in GeneDx Holdings (WGS) for $3,316,880. Following the Form 4 filing with the SEC, Ryan has control over a total of 141,486 shares of the compa...
Nov 19, 2024
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover, from 8:30AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:30AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: WGS
  
  GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
  
  New Biopharma Solution Aims to Accelerate the Delivery of Precision Medicine to More Patients
  STAMFORD, Conn.--(BUSINESS WIRE)--November 19, 2024--
Nov 18, 2024
- GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary, from 8:30AM ET on Monday Nov 18, 2024 by Dow Jones
  8:30AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: WGS
  
  GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
  
  Veteran Legal Executive from Zoetis and Pfizer Joins GeneDx Executive Leadership Team to Lead Legal, Compliance and Policy Functions

Nov 19, 2024
- NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment, from 8:15AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:15AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: NEO
Nov 14, 2024
- DJ Addus HomeCare Price Target Maintained With a $136.00/Share by RBC Capital, from 12:01PM ET on Thursday Nov 14, 2024 by Dow Jones
  12:01PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ADUS
- Felicia Williams Joins NeoGenomics Board of Directors, from 8:10AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:10AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: NEO
Nov 13, 2024
- RBC Lifts Price Target on LTC Properties to $36 From $34, Keeps Sector Perform rating, from 7:57AM ET on Wednesday Nov 13, 2024 by MT Newswires
  7:57AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: LTC
Nov 12, 2024
- Addus HomeCare to Participate in Stephens Annual Investment Conference, from 11:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  11:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ADUS
Nov 8, 2024
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: NEO
Nov 6, 2024
- LTC to Participate in Nareit's REITworld: 2024 Annual Conference, from 6:39PM ET on Wednesday Nov 06, 2024 by Dow Jones
  6:39PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: LTC
- DJ Addus HomeCare Is Maintained at Overweight by Stephens & Co., from 1:45PM ET on Wednesday Nov 06, 2024 by Dow Jones
  1:45PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: ADUS
- DJ Addus HomeCare Is Maintained at Outperform by RBC Capital, from 11:26AM ET on Wednesday Nov 06, 2024 by Dow Jones
  11:26AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: ADUS
- RBC Capital Adjusts Price Target on Addus HomeCare to $136 From $141, Maintains Outperform Rating, from 10:33AM ET on Wednesday Nov 06, 2024 by MT Newswires
  10:33AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: ADUS

GeneDx Holdings Corp
NASDAQ:WGSUnited States

Search Criteria

Today

DJ Sleep Number, Getty Images, and More Stocks See Action From Activist Investors -- Barrons.com, from 4 hours ago by Dow Jones

Nov 22, 2024

GeneDx to Participate in Upcoming Investor Conference, from 4:05PM ET on Friday Nov 22, 2024 by Dow Jones

GeneDx Holdings Insider Sold Shares Worth $3,316,880, According to a Recent SEC Filing, from 3:09AM ET on Friday Nov 22, 2024 by MT Newswires

Nov 19, 2024

GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover, from 8:30AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary, from 8:30AM ET on Monday Nov 18, 2024 by Dow Jones

Peers Headlines

Nov 19, 2024

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment, from 8:15AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 14, 2024

DJ Addus HomeCare Price Target Maintained With a $136.00/Share by RBC Capital, from 12:01PM ET on Thursday Nov 14, 2024 by Dow Jones

Felicia Williams Joins NeoGenomics Board of Directors, from 8:10AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

RBC Lifts Price Target on LTC Properties to $36 From $34, Keeps Sector Perform rating, from 7:57AM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 12, 2024

Addus HomeCare to Participate in Stephens Annual Investment Conference, from 11:00AM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 8, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 6, 2024

LTC to Participate in Nareit's REITworld: 2024 Annual Conference, from 6:39PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Addus HomeCare Is Maintained at Overweight by Stephens & Co., from 1:45PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Addus HomeCare Is Maintained at Outperform by RBC Capital, from 11:26AM ET on Wednesday Nov 06, 2024 by Dow Jones

RBC Capital Adjusts Price Target on Addus HomeCare to $136 From $141, Maintains Outperform Rating, from 10:33AM ET on Wednesday Nov 06, 2024 by MT Newswires